Suppr超能文献

相似文献

1
GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.
Curr Opin Lipidol. 2007 Aug;18(4):389-96. doi: 10.1097/MOL.0b013e3281527914.
4
GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins.
J Lipid Res. 2009 Apr;50 Suppl(Suppl):S57-62. doi: 10.1194/jlr.R800030-JLR200. Epub 2008 Oct 14.
5
Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution.
Biochim Biophys Acta. 2007 Dec;1771(12):1464-8. doi: 10.1016/j.bbalip.2007.10.005. Epub 2007 Oct 22.
6
GPIHBP1 and lipolysis: an update.
Curr Opin Lipidol. 2009 Jun;20(3):211-6. doi: 10.1097/MOL.0b013e32832ac026.
7
Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells.
Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):176-82. doi: 10.1161/ATVBAHA.110.214718. Epub 2010 Oct 21.
9
GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
J Lipid Res. 2011 Nov;52(11):1869-84. doi: 10.1194/jlr.R018689. Epub 2011 Aug 15.
10
The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.
J Biol Chem. 2008 Oct 24;283(43):29554-62. doi: 10.1074/jbc.M802579200. Epub 2008 Aug 18.

引用本文的文献

1
Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease.
J Pharm Pharm Sci. 2024 Jul 16;27:13199. doi: 10.3389/jpps.2024.13199. eCollection 2024.
2
A unified model for regulating lipoprotein lipase activity.
Trends Endocrinol Metab. 2024 Jun;35(6):490-504. doi: 10.1016/j.tem.2024.02.016. Epub 2024 Mar 23.
4
Estimation of Metabolic Effects upon Cadmium Exposure during Pregnancy Using Tensor Decomposition.
Genes (Basel). 2022 Sep 22;13(10):1698. doi: 10.3390/genes13101698.
5
Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart.
Biomolecules. 2021 Jul 12;11(7):1016. doi: 10.3390/biom11071016.
7
Lipoprotein lipase reaches the capillary lumen in chickens despite an apparent absence of GPIHBP1.
JCI Insight. 2017 Oct 19;2(20):96783. doi: 10.1172/jci.insight.96783.
9
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
Kidney Int. 2016 Jul;90(1):41-52. doi: 10.1016/j.kint.2016.02.026. Epub 2016 Apr 26.
10
The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.
Open Biol. 2016 Apr;6(4):150272. doi: 10.1098/rsob.150272.

本文引用的文献

2
Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue.
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17450-5. doi: 10.1073/pnas.0604026103. Epub 2006 Nov 6.
3
A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing "apoB39-only" mice with mouse apoB48.
Biochim Biophys Acta. 2006 Feb;1761(2):182-5. doi: 10.1016/j.bbalip.2006.02.004. Epub 2006 Mar 6.
4
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
Curr Opin Lipidol. 2006 Apr;17(2):122-7. doi: 10.1097/01.mol.0000217892.00618.54.
5
Apolipoprotein AV: low concentration, high impact.
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2445-7. doi: 10.1161/01.ATV.0000193889.65915.f9.
7
Give me A5 for lipoprotein hydrolysis!
J Clin Invest. 2005 Oct;115(10):2694-6. doi: 10.1172/JCI26712.
8
Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants.
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2573-9. doi: 10.1161/01.ATV.0000186189.26141.12. Epub 2005 Sep 15.
9
Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism.
J Biol Chem. 2005 Jul 8;280(27):25383-7. doi: 10.1074/jbc.M501589200. Epub 2005 May 6.
10
Cellular signaling by fibroblast growth factor receptors.
Cytokine Growth Factor Rev. 2005 Apr;16(2):139-49. doi: 10.1016/j.cytogfr.2005.01.001. Epub 2005 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验